The Monsenso solution empowers CROs and pharmaceutical companies to capture real-world data, unlocking revealing insight that enhance a trial’s efficacy and can help speed up the drug development process.
As our agile solution enables you to remotely assess all your subjects 24/7 during the entire length of the clinical trial, it can help increase trial participation, reach larger trial groups and reduce dropout.
Partner with us to obtain a bespoke and tailored solution, ensuring we deliver upon your requirements.
Book a demo
Collect patient reported outcomes (ePRO) i.e. self-assessments, daily diary, along with usage data, sensor data and data on voice analysis.
The data can be viewed and analysed easily by clinicians and extracted to investigators for data analysis.
Monsenso can help improve medication adherence and treatment compliance through daily reminders.
Increase trial participation and engagement by remotely monitoring your subjects.
Monsenso adheres to the highest security standards. It is classified as a class 1 CE device, and holds a TGA certification and a Cyber Essentials Certification.
Additionally, Monsenso A/S holds the ISO 13485 and the ISO 27001 certifications.
The solution is highly scalable and can be used by small clinics, large hospitals, trusts or healthcare regions. Furthermore, it can also be configured to suit individual clinics and disorders.